Occudo Quantitative Strategies’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-14,519
Closed -$188K 1057
2023
Q2
$188K Buy
+14,519
New +$165K 0.02% 862
2022
Q2
Sell
-70,103
Closed -$760K 1195
2022
Q1
$760K Buy
70,103
+32,870
+88% +$399K 0.06% 475
2021
Q4
$524K Buy
+37,233
New +$613K 0.05% 598
2021
Q1
Sell
-13,171
Closed -$59K 797
2020
Q4
$59K Buy
+13,171
New +$59.6K 0.02% 612

Other funds holding DVAX

Occudo Quantitative Strategies's DVAX Position: Q3 2023 in Review

Occudo Quantitative Strategies sold out of Dynavax Technologies (DVAX) in Q3 2023, closing a stake of 14,519 shares — an estimated $188K sold.

Occudo Quantitative Strategies first reported a position in DVAX in Q4 2020 and held it in 4 quarters. The position peaked at $760K in Q1 2022. 225 funds tracked by Wall St. Rank hold DVAX as of Q3 2023.

  • Occudo Quantitative Strategies reported no remaining Dynavax Technologies position as of Q3 2023 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 14,519 Dynavax Technologies shares in Q3 2023, an estimated $188K.
  • Occudo Quantitative Strategies first reported a position in Dynavax Technologies in Q4 2020 and held it in 4 quarters.
  • Occudo Quantitative Strategies's Dynavax Technologies position peaked at $760K in Q1 2022.
  • 225 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2023.

Based on Occudo Quantitative Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.